rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sharmila Dissanaike

Director

Company insider

Files Form 4 as: Director, Heron Therapeutics.

In numbers

Trades disclosed
12
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
22 Dec 2021
Last trade
30 Jan 2026
Last filed
3 Feb 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
HRTX Heron TherapeuticsDirector · Biotechnology · last 30 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Jan 2026filed 3 Feb 2026HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—53,960 at $0.00filing
30 Jan 2026filed 3 Feb 2026HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—53,960 at $0.00filing
31 Jan 2025filed 4 Feb 2025HRTX Heron Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—35,900 at $0.00filing
31 Jan 2025filed 4 Feb 2025HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—17,950 at $0.00filing
30 Jan 2025filed 3 Feb 2025HRTX Heron Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A$62K35,900 at $1.73filing
30 Jan 2025filed 3 Feb 2025HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—17,950 at $0.00filing
19 Jan 2024filed 19 Jan 2024HRTX Heron Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—83,685 at $0.00filing
19 Jan 2024filed 19 Jan 2024HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—13,948 at $0.00filing
16 Dec 2022filed 20 Dec 2022HRTX Heron Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—77,160 at $0.00filing
16 Dec 2022filed 20 Dec 2022HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—38,580 at $0.00filing
22 Dec 2021filed 23 Dec 2021HRTX Heron Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,903 at $0.00filing
22 Dec 2021filed 23 Dec 2021HRTX Heron TherapeuticsBiotechnologySEC FORM 4 Code A—10,452 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Duarte IraEVP, Chief Financial Officer · EVP, Chief Financial Officer at Heron Therapeutics, Inc. /de/, filing Form 4 there in the last year
Craig A. CollardChief Executive Officer · Chief Executive Officer at Heron Therapeutics, Inc. /de/, filing Form 4 there in the last year
William P. ForbesEVP, Chief Development Officer · EVP, Chief Development Officer at Heron Therapeutics, Inc. /de/, filing Form 4 there in the last year
Mark Earl HensleyChief Operating Officer · Chief Operating Officer at Heron Therapeutics, Inc. /de/, filing Form 4 there in the last year
Adam MorganDirector · Director at Heron Therapeutics, Inc. /de/, filing Form 4 there in the last year